Cathy has the unique combination of over 25 years of Fortune 500 and entrepreneurial business experience. Her career started at Procter and Gamble and then Schering-Plough, where at both companies she won awards for her outstanding leadership and business performance.
In 1999 Cathy founded and built Vital Science Corp. which became a leading, profitable dermatology company that was eventually sold to Valeant Pharmaceuticals in 2010. In 2013, she then launched her own Life Science advisory firm contributing to start-ups growing to multi-billion dollar market caps and closed over $500M in transactions.
John has over 20 years of life sciences business development experience. He has driven dozens of transactions ranging from discovery stage through multi-billion dollar M&A. Prior to founding Shadow Lake Group Inc., John was Director of Business Development & Licensing at Mallinckrodt Pharmaceuticals, where he completed a series of transactions through the company's spin out from Covidien.
John was also Senior Director of Intellectual Property and Licensing at Neuromed Pharmaceuticals. He started his career at the University Industry Liaison Office at the University of British Columbia, where he was responsible for life sciences technology licensing and start-up company formation.